Literature DB >> 7682906

Optimum treatment of staphylococcal infections.

J Turnidge1, M L Grayson.   

Abstract

Serious staphylococcal infections remain a significant clinical problem despite advances in antibacterial therapy. Resistance to penicillin is common and methicillin-resistant staphylococci have become troublesome nosocomial pathogens in many institutions. Penicillinase-resistant penicillins (e.g. flucloxacillin, cloxacillin and oxacillin) are the preferred drugs for all methicillin-susceptible staphylococcal infections, although first generation cephalosporins, beta-lactam/beta-lactamase inhibitor combinations, clindamycin, and occasionally erythromycin and cotrimoxazole (trimethoprim/sulfamethoxazole) are alternatives. Serious infections due to methicillin-resistant staphylococci should be treated with parenteral vancomycin. Teicoplanin, where available, is a suitable alternative. Rifampicin, fusidic acid and some fluoroquinolones may be useful oral alternatives, although resistance develops rapidly if they are used as single agents. Cotrimoxazole and minocycline have also proven useful when strains are susceptible. Staphylococcal toxic shock syndrome often requires aggressive resuscitation and anti-staphylococcal therapy for generally 10 to 14 days. Staphylococcus aureus bacteraemia remains a life-threatening condition which, in all but one-third of cases, is associated with an underlying septic focus such as endocarditis, osteomyelitis or occult abscess. Differentiating between complicated and uncomplicated bacteraemia is critical to define the appropriate treatment regimen. Serious staphylococcal sepsis such as endocarditis and acute osteomyelitis generally requires prolonged (4 to 6 weeks) antibiotic treatment. Coagulase-negative staphylococci are the commonest cause of prosthetic device infection, and generally require prolonged therapy with an agent to which they have proven to be sensitive, e.g. a penicillinase-resistant penicillin or vancomycin. Removal of infected foreign or prosthetic material, and drainage of deep collections remain a critical aspect of all therapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7682906     DOI: 10.2165/00003495-199345030-00004

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  22 in total

Review 1.  Chloramphenicol. Are concerns about aplastic anaemia justified?

Authors:  P Flegg; I Cheong; P D Welsby
Journal:  Drug Saf       Date:  1992 May-Jun       Impact factor: 5.606

2.  Pacemaker infections. A clinical study with special reference to prophylactic use of some isoxazolyl penicillins.

Authors:  G Bluhm
Journal:  Acta Med Scand Suppl       Date:  1985

Review 3.  Methicillin-resistant staphylococci.

Authors:  H F Chambers
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

Review 4.  Staphylococcal endocarditis. Laboratory and clinical basis for antibiotic therapy.

Authors:  A W Karchmer
Journal:  Am J Med       Date:  1985-06-28       Impact factor: 4.965

5.  Increased amounts of a novel penicillin-binding protein in a strain of methicillin-resistant Staphylococcus aureus exposed to nafcillin.

Authors:  H F Chambers; B J Hartman; A Tomasz
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

Review 6.  Infections associated with prosthetic devices: magnitude of the problem.

Authors:  B Sugarman; E J Young
Journal:  Infect Dis Clin North Am       Date:  1989-06       Impact factor: 5.982

7.  A national survey of antimicrobial resistance in Staphylococcus aureus in Australian teaching hospitals.

Authors:  J Turnidge; P Lawson; R Munro; R Benn
Journal:  Med J Aust       Date:  1989-01-16       Impact factor: 7.738

8.  Staphylococcus aureus bacteremia. Current clinical patterns.

Authors:  C M Nolan; H N Beaty
Journal:  Am J Med       Date:  1976-04       Impact factor: 4.965

9.  Oral antimicrobial therapy for adults with osteomyelitis or septic arthritis.

Authors:  J Black; T L Hunt; P J Godley; E Matthew
Journal:  J Infect Dis       Date:  1987-05       Impact factor: 5.226

10.  Oral antibiotic therapy for skeletal infections of children. II. Therapy of osteomyelitis and suppurative arthritis.

Authors:  T R Tetzlaff; G H McCracken; J D Nelson
Journal:  J Pediatr       Date:  1978-03       Impact factor: 4.406

View more
  15 in total

1.  Fusidic acid monotherapy.

Authors:  V Vassiliou; A K Demetriades; G Scott
Journal:  J R Soc Med       Date:  2002-05       Impact factor: 5.344

Review 2.  The treatment of staphylococcal infections with special reference to pharmacokinetic, pharmacodynamic and pharmacoeconomic considerations.

Authors:  R Janknegt
Journal:  Pharm World Sci       Date:  1997-06

3.  Comparative Study of Teicoplanin vs Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteraemia.

Authors:  C Y Liu; W S Lee; C P Fung; N C Cheng; C L Liu; S P Yang; S L Chen
Journal:  Clin Drug Investig       Date:  1996-08       Impact factor: 2.859

Review 4.  Methicillin-resistant staphylococci in clean surgery. Is there a role for prophylaxis?

Authors:  E Mini; S Nobili; P Periti
Journal:  Drugs       Date:  1997       Impact factor: 9.546

Review 5.  Diagnosis and management of osteomyelitis. Decision analytic and pharmacoeconomic considerations.

Authors:  M Tavakoli; P Davey; B A Clift; H T Davies
Journal:  Pharmacoeconomics       Date:  1999-12       Impact factor: 4.981

Review 6.  Penicillins. A current review of their clinical pharmacology and therapeutic use.

Authors:  Dilip Nathwani; Martin J Wood
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

7.  Ambulatory treatment of multidrug-resistant Staphylococcus-infected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole).

Authors:  A Stein; J F Bataille; M Drancourt; G Curvale; J N Argenson; P Groulier; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

Review 8.  Pharmacokinetic interactions with rifampicin : clinical relevance.

Authors:  Mikko Niemi; Janne T Backman; Martin F Fromm; Pertti J Neuvonen; Kari T Kivistö
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

9.  Evaluation of a new Etest vancomycin-teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA), in particular, heterogeneous GISA.

Authors:  Anne Yusof; Anette Engelhardt; Asa Karlsson; Lina Bylund; Pamela Vidh; Karen Mills; Mandy Wootton; Timothy R Walsh
Journal:  J Clin Microbiol       Date:  2008-07-02       Impact factor: 5.948

10.  Specific detection of methicillin-resistant Staphylococcus species by multiplex PCR.

Authors:  P Vannuffel; J Gigi; H Ezzedine; B Vandercam; M Delmee; G Wauters; J L Gala
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.